XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net (loss) income $ (890) $ 10,541
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 23,818 24,574
Amortization of intangibles 13,211 15,315
Amortization of deferred financing costs 2,085 2,596
Amortization of mortgage discounts 227 251
Amortization of below-market lease liabilities (817) (965)
Amortization of above-market lease assets 1,556 1,071
Amortization related to right-of-use assets 216 224
Amortization of lease incentives and commissions 424 272
Bad debt expense 0 0
Unbilled straight-line rent (1,888) (2,853)
Termination fee receipt 0 9,003
Equity-based compensation 2,925 2,727
Unrealized gains on foreign currency transactions, derivatives, and other 2,647 (4,210)
Lease incentive and commission payments (1,611) (2,315)
Impairment charges 0 230
Changes in operating assets and liabilities, net:    
Prepaid expenses and other assets 8,814 (475)
Accounts payable and accrued expenses 2,905 2,361
Prepaid rent 9,393 3,472
Net cash provided by operating activities 63,015 61,819
Cash flows from investing activities:    
Investment in real estate and real estate related assets (81,362) 0
Capital expenditures (7,440) (1,782)
Net cash used in investing activities (88,802) (1,782)
Cash flows from financing activities:    
Borrowings under revolving credit facilities 91,040 35,000
Principal payments on mortgage notes payable (4,623) (14,065)
Dividends paid on Common Stock (41,658) (41,566)
Distributions to non-controlling interest holders (100) (100)
Net cash provided by (used in) financing activities 39,539 (23,351)
Net change in cash, cash equivalents and restricted cash 13,752 36,686
Effect of exchange rate changes on cash 2,396 (1,923)
Cash, cash equivalents and restricted cash, beginning of period 104,445 93,311
Cash, cash equivalents and restricted cash, end of period 120,593 128,074
Cash and cash equivalents, end of period 119,161 123,502
Restricted cash, end of period 1,432 4,572
Cash, cash equivalents and restricted cash, end of period 120,593 128,074
Non-Cash Activity:    
Accrued capital expenditures 4,349 969
Common Stock    
Cash flows from financing activities:    
Common Stock issuance costs (21) 0
Series B Preferred Stock    
Cash flows from financing activities:    
Series B Preferred Stock issuance proceeds, net 0 2,396
Dividends paid on Preferred Stock (2,018) (1,935)
Series A Preferred Stock    
Cash flows from financing activities:    
Dividends paid on Preferred Stock $ (3,081) $ (3,081)